Vietnam DAV + Law on Pharmacy framework for research peptide imports — Vietnamese regulatory landscape for HCMC / Hanoi researchers

Vietnam DAV structure: the Drug Administration of Vietnam (Cục Quản lý Dược) operates under the Ministry of Health (Bộ Y Tế). DAV oversees pharmaceutical product registration, import licensing, GMP inspections, and Vietnam's participation in the ASEAN Common Technical Dossier (ACTD) framework for pharmaceutical regulation. Importing a drug without a Vietnamese marketing authorisation needs a Ministry of Health import licence; the licence procedure for clinical trials, testing samples and scientific research is listed on the National Single Window.

Law on Pharmacy: under Article 60 of the Law on Pharmacy (No. 105/2016/QH13, consolidated text as amended through 2025), a drug without a Vietnamese marketing authorisation is licensed for import, and may be imported only up to the quantity in the import licence, in listed cases that include scientific research. PeptideGuide found no Vietnamese source for a "Pharmaceutical Master Plan" or any other rule that creates a research-grade or research-use-only import category.

Customs Department interception patterns: Vietnam Customs operates risk-based screening at primary international ports — Tan Son Nhat (HCMC, the highest-volume entry point), Noi Bai (Hanoi), Da Nang International Airport, Cam Ranh (Khanh Hoa). PeptideGuide has no data on import volumes, interception rates or clearance times by port or origin.

Personal-import declaration process: PeptideGuide found no Vietnamese source for a personal-research or research-use-only import declaration. The National Single Window lists the Ministry of Health's licence for importing drugs for scientific research among its procedures; PeptideGuide has no data on how Vietnamese customs treats research-labelled parcels.

Currency + payment friction — the structural Vietnamese gap: Vietnamese dong (VND) is the local currency. International vendors price in USD/GBP/EUR — Vietnamese buyers convert via international card payment or Vietnamese bank wire (with currency conversion overhead). Credit card support across Pharma Lab Global, SwissChems, and most consumer vendors is the typical payment path. The conversion cost depends on the bank.

Institutional research import path: importing a drug without a Vietnamese marketing authorisation for scientific research needs a Ministry of Health import licence under Article 60 of the Law on Pharmacy. PeptideGuide found no published procedure specific to universities such as Vietnam National University, Hanoi Medical University or the HCMC University of Medicine and Pharmacy; the institution's procurement office is the place to ask.

Vietnamese language considerations: Vietnamese (Tiếng Việt) interface support across the international consumer peptide vendor segment is minimal — Pharma Lab Global, Direct Peptides, SwissChems, and others operate English-only. English comfort among Vietnamese university researchers is moderate-to-high (HCMC + Hanoi research communities operate in English for international-research-language contexts), so the language gap is less severe than for Thai-only or Indonesian-only buyers. For Vietnamese-language preferred buyers, Milo-Lab (SEA-regional with some regional language support) is operationally closer than UK/US international vendors.

Vendor recommendations for Vietnamese buyers 2026:

1. The Thai vendors (Milo-Lab, Bangkok Peptides) are not an option: Vietnam is on neither vendor's shipping destination list (checked on their shipping pages, updated August and September 2026).

2. Pharma Lab Global UK — for institutional researchers and individual buyers. 10-18 day UK-Vietnam shipping.

3. SwissChems US — only when specific catalog SKUs Pharma Lab Global doesn't stock are needed.

4. Cross-border to Singapore: AVOID — same hard rule as for Thai buyers. Singapore HSA framework is the strictest in SEA.

YMYL caveat for Vietnamese researchers: research peptides are NOT registered Vietnamese pharmaceutical products. Therapeutic-context use of unapproved imports falls outside Vietnamese medical practice frameworks. Vietnamese healthcare practitioners administering unapproved-imports face Ministry of Health professional-conduct review and potential Medical Council action. PeptideGuide found no Vietnamese source saying a research-use-only label creates an import route. See research-use-only labeling explained for the broader regulatory framing.

More from this region.

Other articles covering this region's vendors, regulatory framework, and research peptides.

• 2026-11-02Earlier versions called Vietnam the second-largest SEA market for research peptides after Indonesia, with a growing university-affiliated research community. PeptideGuide holds no market data; the claim was removed.
• 2026-11-01Earlier versions said a Vietnamese "Pharmaceutical Master Plan" defines a research-grade import category that covers research-use-only imports, that personal-research-quantity imports under research-use-only declarations are legal, that a "Drug Import Division" handles them, that they are declared through the National Single Window with a research-use-only self-declaration, that only commercial quantities need a DAV licence, and that universities have established import frameworks. PeptideGuide found no Vietnamese source for these claims. Article 60 of the Law on Pharmacy says a drug without a Vietnamese marketing authorisation is imported only under an import licence, up to the licensed quantity, in listed cases including scientific research; the page now says so. A 3–7% currency-conversion overhead, which the 2026-10-13 correction had withdrawn, was still listed as a drawback; it was removed.
• 2026-10-31Earlier versions recommended QSC Peptides (removed in October 2026 after its store went offline) for Vietnamese buyers. The vendor list and cryptocurrency FAQ were updated.
• 2026-10-13Earlier versions put the currency-conversion overhead at 3–7% and said Vietnam has higher cryptocurrency adoption than other SEA markets. PeptideGuide holds no data for either; both were removed.
• 2026-10-08Earlier versions said UK-origin parcels clear Vietnamese customs more cleanly than US-origin ones, that personal imports clear at high or acceptable rates, that Ho Chi Minh City handles most research-peptide imports, that DAV documentation requests are uncommon, that orders of 20 or more vials need split shipping to avoid licensing, and gave average clearance times by port and origin. The summary also recommended Milo-Lab, which does not ship to Vietnam. PeptideGuide holds no clearance data; the claims were removed.